A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects. - Test2 - elhamkhani - TriplyDB

A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.

A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.

http://www.wikidata.org/entity/Q37947594

about

Identification of small molecules with type I interferon inducing properties by high-throughput screening.Interferon-λ1 suppresses invasion and enhances autophagy in human osteosarcoma cell.Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.Pharmacokinetic studies of the recombinant chicken interferon-α in broiler chickens.Investigations of interferon-lambda for the treatment of cancer.Recombinant adenovirus expressing hIFN-λ1 inhibits gastric adenocarcinoma cell line SGC-7901 proliferation Emerging nanotechnologies for cancer immunotherapy

P2860

Q34473943-1714FDD5-D985-4001-BE5D-C8534D98156C Q36317399-6A907F0D-8387-4D86-AF61-F8765293569B Q36694881-9938FB46-22C4-4696-9D7B-B6422185FCA1 Q37667570-2FC7DAA5-BB2A-4500-B6FD-9F12548094E7 Q38347596-7351DA67-4CB7-4FE3-992B-D35C02654650 Q38794769-9A877455-A6E3-4543-94AD-6C88A5DA1F58 Q38837036-A340EC4A-D58E-4A96-9BC0-CC5530340B49

P2860

A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.

http://www.wikidata.org/entity/Q37947594

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

A possible anticancer agent, t ...... nd produces antitumor effects.

@en

A possible anticancer agent, t ...... nd produces antitumor effects.

@nl

type

label

A possible anticancer agent, t ...... nd produces antitumor effects.

@en

A possible anticancer agent, t ...... nd produces antitumor effects.

@nl

prefLabel

A possible anticancer agent, t ...... nd produces antitumor effects.

@en

A possible anticancer agent, t ...... nd produces antitumor effects.

@nl

P1433

Q37947594-9847FFB0-C5FB-4227-A988-EAE6EC737782

P1476

Q37947594-C7968ADF-8556-4DA6-B48E-75A3D3728E22

P2093

Q37947594-233859FE-92B6-48A9-9A65-164CF699E486

Q37947594-29DEFADF-8130-486A-B2BC-73B7E636667A

Q37947594-30E2CD7A-98BE-42E5-9466-5D3B2FB4FE6B

Q37947594-5C354435-E553-4C6C-9C5F-C15687F68EFF

Q37947594-BC0FFB14-6C21-44D5-B05A-D60AEEA0F1D5

P275

Q37947594-06FCC20F-1810-4164-B836-37E76D5B07AE

P2860

Q37947594-0458B304-5CA7-4655-9EB8-4C51353BD889

Q37947594-1406CFBD-4899-4F36-AFAD-C42B9DE61F77

Q37947594-1ACC425F-2599-49C6-A55F-0D2FFE096BB6

Q37947594-2B929585-6402-43E8-B473-3DE3D410FF0B

Q37947594-3788C99B-8BFF-42F3-A271-4FDEC0EF2A0F

Q37947594-4CFDF2DD-DC5A-46C8-AC6D-E5897B0D87AE

Q37947594-4D17D88D-F5BB-4330-9495-8577EE8A267D

Q37947594-522F2FB2-D3F8-4C29-AF1A-53931F8333CA

Q37947594-54F04BAD-AD0E-41D7-9A92-2796CB58B1A2

Q37947594-6122D588-8615-4C77-8A10-8B2BE157D254

P304

Q37947594-F62BFF9E-60AD-4683-B3A0-4F9789C75DA7

P31

Q37947594-A942E454-4D6C-49C6-BA12-F38AC5BCEA04

P356

Q37947594-B457421B-2906-422D-95B0-100688766564

P478

Q37947594-3B4509F8-7C56-4D72-8E82-9258E6A2B896

P50

Q37947594-12CCE435-6961-4491-BD44-E5BEB94F183B

P5008

Q37947594-0E379E67-242A-4FF4-A0A1-6D82033EE652

P577

Q37947594-3A72A3B0-35FE-4BE4-BE96-C59C90D80FC1

P5875

Q37947594-272B4171-BADC-419D-A75A-A917487C683E

P698

Q37947594-BB6AF031-A55A-41B8-91C8-586ED5E2AB2C

P921

Q37947594-48B9428A-DAE9-4421-A7D0-035E833A91EA

Q37947594-5A7C8B6E-CE07-4A7A-A6AD-680C3B661280

Q37947594-A1EA2185-B0E8-4AFD-B966-964D4AEED46A

P932

Q37947594-C4E31B94-83FF-4C09-904E-48E80E48E8DC

P356

P1433

Clinical and Developmental Immunology

P1476

A possible anticancer agent, t ...... and produces antitumor effects

@en

P2093

Hideaki Shimada

http://www.w3.org/2001/XMLSchema#string

Kenzo Hiroshima

http://www.w3.org/2001/XMLSchema#string

Kiyoko Kawamura

http://www.w3.org/2001/XMLSchema#string

Masatoshi Tagawa

http://www.w3.org/2001/XMLSchema#string

Yuji Tada

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

Biological activity of interleukins-28 and -29: comparison with type I interferons

IL-28, IL-29 and their class II cytokine receptor IL-28R

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

Comparative genomic analysis reveals independent expansion of a lineage-specific gene family in vertebrates: the class II cytokine receptors and their ligands in mammals and fish

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses

Mechanisms of type-I- and type-II-interferon-mediated signalling

P304

479013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/479013

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2011-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51732167

http://www.w3.org/2001/XMLSchema#string

P698

22013482

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

3195555

http://www.w3.org/2001/XMLSchema#string